INNV · XBRL financial data

InnovAge Holding financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (INNV's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Revenue from contracts with customers	637,800	698,640	688,087	763,855	853,699	989,707
Gross profit	—	135,372	101,288	132,064	153,639	227,764
General and administrative	132,333	101,653	115,637	111,337	122,058	166,489
Other operating income (expense)	(18,211)	0	0	—	—	—
Operating income (loss)	(12,337)	(4,406)	(49,395)	(23,180)	(29,761)	2,618
Interest expense	16,787	2,526	—	—	—	—
Other income (expense)	(2,237)	(305)	124	2,542	1,739	1,906
Income tax expense (benefit)	9,771	723	(7,241)	1,402	1,316	949
Net income (loss)	(43,986)	(6,521)	(40,673)	(21,338)	(30,313)	(2,537)
Earnings per share, basic USD per share	(0.36)	(0.05)	(0.30)	(0.16)	(0.22)	(0.02)
Earnings per share, diluted USD per share	(0.36)	(0.05)	(0.30)	(0.16)	(0.22)	(0.02)
Weighted average shares, basic thousands of shares	123,619	135,520	135,594	135,902	135,388	135,699
Weighted average shares, diluted thousands of shares	123,619	135,520	135,594	135,902	135,388	135,699

Fiscal years (INNV's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Cash and cash equivalents	201,466	184,429	127,249	56,946	64,129	97,891
Short-term investments	—	0	46,213	45,833	41,775	43,435
Accounts receivable	32,582	35,907	24,344	48,106	36,373	42,390
Prepaid and other current assets	9,249	—	—	—	24,472	27,311
Total current assets	250,932	240,956	215,229	173,142	176,108	214,313
Property and equipment, net	142,715	176,260	—	—	—	—
Right-of-use asset	—	0	21,210	28,416	26,901	21,412
Goodwill	124,217	124,217	124,217	139,949	142,046	142,046
Total assets	531,752	555,596	567,358	547,661	526,851	557,393
Current portion of long-term debt	3,790	3,793	3,795	3,795	2,250	2,536
Total current liabilities	78,565	105,307	148,450	138,599	164,807	203,891
Long-term debt	71,574	68,210	64,844	61,478	57,464	45,521
Lease liability, non-current	—	0	18,828	26,275	23,918	19,775
Total liabilities	173,787	201,852	252,558	247,853	263,943	288,617
Retained earnings (accumulated deficit)	11,250	4,729	(35,944)	(68,311)	(101,047)	(105,758)
Total stockholders' equity	335,146	332,364	296,299	269,261	234,968	235,603
Total liabilities and equity	531,752	555,596	567,358	547,661	526,851	557,393
Common shares outstanding (cover page) thousands of shares	135,517	135,566	135,878	135,621	135,638	136,451

Fiscal years (INNV's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Net income (loss)	(43,986)	(6,521)	(40,673)	(21,338)	(30,313)	(2,537)
Stock-based compensation	1,664	3,739	4,608	6,832	7,619	7,048
Depreciation and amortization	12,294	13,924	15,419	18,950	19,510	21,142
Net cash from operating activities	(7,548)	27,302	20,236	(36,898)	32,866	64,714
Purchases of property and equipment	17,541	38,238	23,354	7,914	6,263	14,309
Net cash from investing activities	(19,541)	(40,238)	(69,521)	(26,373)	(5,550)	(12,340)
Share repurchases	77,603	—	—	—	—	—
Dividends paid	9,500	—	—	—	—	—
Proceeds from long-term debt	375,000	—	—	—	0	60,082
Repayments of long-term debt	512,660	3,790	3,793	3,795	3,799	71,282
Net cash from financing activities	116,224	(6,318)	(7,896)	(7,034)	(19,082)	(18,531)
Net change in cash	89,135	(19,254)	(57,181)	(70,305)	7,180	33,761

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
InnovAge Holding	119,253	264,757	28,742	136.5M	—	Q1 FY27 10-QSep 30, 2026
DocGo	25,233	73,425	(9,242)*	98.9M	2.7 quarters	Q2 FY26 10-QJun 30, 2026
Strata Critical Medical	35,136	74,081	9,458*	89.3M	—	Q3 FY26 10-QSep 30, 2026
Talkspace	39,159	61,672	11,385*	165.8M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.